UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
ADEZA BIOMEDICAL CORP
---------------------
(Name of Issuer)
Common Stock, $.01 par value per share
--------------------------------------
(Title of Class of Securities)
US0068641028
------------
(CUSIP Number)
April 30, 2005
--------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP No. US0068641028
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
AMVESCAP PLC
2. Check the Appropriate Box if a Member of a Group (see Instructions)
(a) _____________________________________________________
(b) _____________________________________________________
3. SEC Use Only ______________________________________________________
4. Citizenship or Place of Organization
AMVESCAP PLC: England
AIM Advisors, Inc: United States
INVESCO Asset Management Limited: England
INVESCO Institutional (N.A.), Inc.: United States
:
:
:
:
:
:
:
:
5. Sole Voting Power 710,300: Such shares are
held by the following entities in the respective
amounts listed AIM Advisors, Inc 334,500, INVESCO
Asset Management Limited 181,354, INVESCO
Institutional (N.A.), Inc. 194,446
Number of Shares --------------------------------------------------
Beneficially Owned
by Each Reporting 6. Shared Voting Power _______________
Person With --------------------------------------------------
7. Sole Dispositive Power 710,300: Such shares are
held by the following entities in the respective
amounts listed AIM Advisors, Inc 334,500, INVESCO
Asset Management Limited 181,354, INVESCO
Institutional (N.A.), Inc. 194,446
--------------------------------------------------
8. Shared Dispositive Power _______________
9. Aggregate Amount Beneficially Owned by Each Reporting Person
710,300
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) N/A
11. Percent of Class Represented by Amount in Row (9) 4.28%
12. Type of Reporting Person (See Instructions)
IA, HC. See Items 2 and 3 of this statement.
SCHEDULE 13G
Item 1(a) NAME OF ISSUER:
ADEZA BIOMEDICAL CORP
Item 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
1240 Elko Drive
Sunnyvale, CA 94089
Item 2(a) NAME OF PERSON FILING:
AMVESCAP PLC
In accordance with Securities and Exchange Commission Release No.
34-39538 (January 12, 1998), this statement on Schedule 13G or
amendment thereto is being filed by AMVESCAP PLC ("AMVESCAP"), a
U.K. entity, on behalf of itself and its subsidiaries listed in Item
4 of the cover of this statement. AMVESCAP through such subsidiaries
provides investment management services to institutional and
individual investors worldwide.
Executive officers and directors of AMVESCAP or its subsidiaries may
beneficially own shares of the securities of the issuer to which
this statement relates (the "Shares"), and such Shares are not
reported in this statement. AMVESCAP and its subsidiaries disclaim
beneficial ownership of Shares beneficially owned by any of their
executive officers and directors. Each of AMVESCAP's direct and
indirect subsidiaries also disclaim beneficial ownership of Shares
beneficially owned by AMVESCAP and any other subsidiary.
Item 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE:
11 Devonshire Square
London EC2M 4YR
England
Item 2(c) CITIZENSHIP:
See the response to Item 2(a) of this statement.
Item 2(d) TITLE OF CLASS OF SECURITIES:
Common Stock, $.01 par value per share
Item 2(e) CUSIP NUMBER:
US0068641028
Item 3 TYPE OF REPORTING PERSON:
An investment adviser in accordance with section
240.13d-1(b)(1)(ii)(E) A parent holding company or control person in
accordance with section 240.13d-1(b)(1)(ii)(G)
As noted in Item 2 above, AMVESCAP is making this filing on behalf
of its subsidiaries listed herein. Each of these entities is either
an investment adviser registered with the United States Securities
Exchange Commission under Section 203 of the Investment Advisers Act
of 1940, as amended, or under similar laws of other jurisdictions.
AMVESCAP is a holding company.
Item 4 OWNERSHIP:
Please see responses to Items 5-8 on the cover of this statement
which are incorporated herein by reference.
Item 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
N/A
Item 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
N/A
Item 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTING ON BY THE PARENT HOLDING COMPANY:
Please see Item 3 of this statement, which is incorporated herein by
reference.
Item 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
N/A
Item 9 NOTICE OF DISSOLUTION OF A GROUP:
N/A
Item 10 CERTIFICATION:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SIGNATURE:
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
May 15, 2005
Date
/s/ HAL LIEBES
-------------------------
Signature
Hal Liebes
Group Compliance Officer
AMVESCAP PLC
Name/Title